Met Life Investment Management, LLC Prothena Corp Public LTD CO Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Met Life Investment Management, LLC holds 25,873 shares of PRTA stock, worth $320,307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,873
Previous 25,337
2.12%
Holding current value
$320,307
Previous $423,000
15.37%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding PRTA
# of Institutions
197Shares Held
39.4MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$143 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$47.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$45.6 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$27.7 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$23 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $581M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...